Roche taps Dyno Therapeutics' AI-driven capsids for neurological gene therapy
Genetic Engineering & Biotechnology News (GEN) - 15-Jan-2025A partnership advancing synthetic AAV vectors to tackle gene therapy challenges
Join the club for FREE to access the whole archive and other member benefits.
Senior Editor at GEN Biotechnology
Fay Lin is a computational biologist turned science journalist and editor. She is passionate about exploring the impact of artificial intelligence (AI) on the biotech industry, including its applications in drug discovery, precision medicine, sustainability, and beyond.
Visit website: https://www.genengnews.com/author-archive/?author-id=24485
See also
News provider in the fields of biotechnology and genetic engineering
Details last updated 23-Jan-2025
A partnership advancing synthetic AAV vectors to tackle gene therapy challenges